Figure 3.
SNP-stratified tumor marker levels in patients with localized pancreatic ductal adenocarcinoma: All PDAC cases (top panel), Stage I cases only (bottom panel). CA19-9 levels differed within SNP subgroups (FUT2−/− versus other groups and FUT3−/− versus other groups, p<0.00001, Mann-Whitney).